M&T Bank Corp Aerie Pharmaceuticals Inc Transaction History

M&T Bank Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$7.02 - $13.33 $92,186 - $175,049	-13,132 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$11.32 - $16.63 $6,044 - $8,880	534 Added 4.24%	13,132 $149,000
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $7,307 - $9,143	482 Added 3.98%	12,598 $202,000
Q1 2021 May 06, 2021	BUY	$13.12 - $20.9 $17,279 - $27,525	1,317 Added 12.2%	12,116 $217,000
Q4 2020 Feb 12, 2021	SELL	$9.12 - $14.49 $95,386 - $151,550	-10,459 Reduced 49.2%	10,799 $146,000

Q3 2020 Nov 06, 2020	BUY	$10.46 - $14.46 $13,692 - $18,928	1,309 Added 6.56%	21,258 $250,000
Q2 2020 Jul 29, 2020	BUY	$12.0 - $16.13 $61,020 - $82,021	5,085 Added 34.21%	19,949 $295,000
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $61,982 - $133,597	5,235 Added 54.37%	14,864 $200,000
Q4 2019 Feb 07, 2020	BUY	$17.72 - $25.1 $170,625 - $241,687	9,629 New	9,629 $233,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.